Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Affymetrix/Roche microarray

This article was originally published in The Gray Sheet

Executive Summary

GeneChip System 3000Dx, on which Roche's AmpliChip CYP450 test can be run, garners CE mark for diagnostic use in Europe, Affymetrix announces Sept. 1. Roche encountered problems in the U.S. when it sought to market AmpliChip as an analyte-specific reagent, exempt from premarket notification. The firm subsequently said it would offer AmpliChip as a research-use only test in the U.S. until further notice (1"The Gray Sheet" Aug. 9, 2004, p. 13)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020821

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel